≡ Menu

When to appeal SSDI denial and when to open a new claim

Statistically when applying for SSDI benefits chances are you will be denied. A denial leaves you with three choices: Accept the denial and forget it. Appeal the denial. Make a fresh application. The first consideration is why you were denied. If it was for a technical reason, like you are still working and making too… Read More

Methadone as a chronic pain management tool

One of the main issues when prescribing medication for chronic pain is how much medication should be given and at what frequency. The result is that patient follow up care requires regular office visits and for the staff a lot of additional paperwork. The Pain Centre of Montreal University Health Centre has found an unique… Read More

New memory formation observed after learning

Gary Lynch, professor of psychiatry and human behavior at UC Irvine, achieved a century-old dream of neuroscientists---to observe changes in brain cell connections following a period of learning. Synaptic connections, critical to learning, were observed to change in rats' brains after they learned to navigate a new, complex environment. A control group of rats were… Read More

Alzheimer’s may be related to cancer protein

The tau protein is thought to poison nerve cells in the brain, which is one of the hallmarks of Alzheimer's disease. Chad Dickey, PhD, assistant professor of molecular pharmacology and physiology, University of South Florida (USF), has found that cancer related protein Akt may influence the fate of the tau protein that leads to bundles… Read More

Forum for people with neurological disorders and diseases

NeuroTalk Communities is a great place to learn (and share) neurological issues. Forums include: allergies, ALS, alzheimer, aneurysm, arthritis, autism, autoimmune diseases, cerebral palsy, children's health, chronic pain, diabetes, epilepsy, fibromyalgia, gluten sensitivity, headache, hydrocephalus, and lyme disease… Read More

PTSD may be helped by ‘memory’ enzyme

Most current theories of how we form long-term memories is that they are encoded in our brain by changes in the connections between neurons, which would not allow them to be erased chemically. Recent research contradicts that theory by suggesting the enzyme PKMzeta, may actually be required to sustain memories. By targeting, new therapies could… Read More

Chronic pain in the workplace

In 1996 employees who reported chronic pain and continued to work was 19%. In 2006 the rate raised to 26% as reported by Pain And Work and done in partnership with the NationalPainFoundation.org… Read More

Traumatic event can make permanent changes in stress hormone level

What is already known is that post-traumatic stress disorder (PTSD), or depression, can change how a person responds to stress. What is not known is how a traumatic event effects a person even though they may not develop clinical symptoms. Normally, when a person experiences stress their is a boost in cortisol output. After the stressful… Read More

Bullying linked to adulthood anxiety and depression

Bullying is most often discussed as being an adolescence issue and left behind once out of high school. Research now indicates that effects of bullying may linger well into early adulthood. Allison Dempsey, doctoral student, University of Florida College of Education, studied the effects of bullying on 210 college students. Primarily, Dempsey asked participants about… Read More

Antidepressant studies overly optimistic

An examination of published studies of 12 widely prescribed antidepressant drugs, approved between 1981 and 2004, showed a discrepancy in results from FDA studies. Erick Turner, M.D., Medical Director of the Portland Veterans Affairs Medical Center's Mood Disorders Program, reviewed the FDA's trials for 12 widely prescribed antidepressant drugs and compared the result with the literature… Read More

Depression treatments using SSRI and venlafaxine compared

Despite the numerous antidepressant medications available for treatment many depressed patients continue to experience symptoms of depression. Charles B. Nemeroff, affiliated with the Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, and associates, reviewed 34 double-blind randomized controlled trials that compared a single serotonin-norepinephrine reuptake inhibitor (SNRI), venlafaxine, to other… Read More

Alzheimer’s origins revealed in 3-D

The origins of Alzheimer's disease is thought to be the result of A-beta peptide (Alzheimer's peptide) when it clumps together in the brain and forms long fibrils. Whether it is the protein clumps or the fibrils that kill brain neurons is still being debated. Nikolaus Grigorieff, biophysicist, Brandeis University, along with researchers at Leibniz Institut… Read More

Terms of Use
Privacy Policy
FTC Statement
Medical Disclaimer
Affiliate Disclosure